EpiPen. HIV Drugs. Hep C Treatment. Insulin.

The list of drugs that have grabbed headlines for dizzyingly high prices are just the tip of the iceberg. Pharmaceutical companies’ habit of pushing the limits on drug prices is costing states like California billions and driving up the cost of healthcare.

Enough is enough. It’s time for solutions.

California Takes On Out-of-Control Prescription Drug Pricing

The pharmaceutical industry spent years stalling transparency legislation in the state legislature but, California families made progress this year with the passage of SB 17. There’s more to be done, but this landmark legislation will pave the way for more sustainable, affordable prescription drug prices.

Stay Informed

Stay up to date on the fight against runaway prescription drug prices.
16 hours ago
Despite only generating 22% of its revenue, Big Pharma collected more than 60% of the healthcare industry’s overall profits last quarter https://t.co/J6VOxgyuSr
5 days ago
“Whatever the industry’s excuses, shenanigans like these cannot be justified as aiding innovation. Instead they are anticompetitive abuses that lead to higher prices for millions of patients in need of vital drugs.” https://t.co/cpfHMFShpJ
7 days ago
RunawayRx’s most recent Dose of Reality is hot off the press. Read up on the latest in #BigPharma’s drug pricing antics here: https://t.co/LU6Y0zqlaQ https://t.co/c27rPNlotu
1 week ago
“85 percent of people diagnosed with chronic hepatitis C will not receive treatment this year. Why? A single course of treatment can cost as much as $94,000.” https://t.co/ruIIYI1pzx

Transparency in Drug Pricing

Health coverage protects us from most of Big Pharma’s price gouging, but drugs with six-figure price tags drive up the cost of care for everyone.
In 2017, California passed SB 17 to bring pharmaceutical companies’ pricing tactics out of the dark and begin to address the growing affordability crisis. The bill, which will serve as a model for the nationwide push to address rising prescription drug prices, came on the tails of truly outrageous price hikes, like Mylan’s decision to needlessly up the price of EpiPens by nearly 500 percent and Gilead Sciences’ pricing of a lifesaving treatment at $1,000 per pill. While examples like these are widely known, the pharmaceutical industry has been quietly upping the price of old and new drugs alike. This destructive practice has led prescription drug prices to become the fastest growing portion of the health care dollar.

SB 17 Will:

Give A Heads
Up On
Price Hikes

Price Hike Alerts - Icon
Drug companies will give payers notice of major price increases for the most expensive drugs

Help Plan

Planning for Increases - Icon
Payers can plan ahead for significant price increases on medications

Provide Data
To Inform

Informed Solutions - Icon
Lawmakers can review historical trends on drug costs to inform solutions


Public Accountability - Icon
Public will have access to basic information on what drives price hikes and drug spending